Published in Biotech Business Week, November 7th, 2005
Currently, Blease distributes a complete range of anesthesia systems and ventilators internationally to approximately 90 countries but not currently to the United States. FDA 510(k) approval clears the way for the company's flagship system to be sold in the United States, where annual sales of anesthesia systems and ventilators is approximately $429 million, as estimated by independent business consultants, Frost &...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.